Mangoceuticals (MGRX) Inventory Average (2023 - 2024)
Mangoceuticals (MGRX) reported Inventory Average of -$2644.0 for Q4 2024, down 113.19% on a YoY basis from $20041.0 in Q1 2024, and down 119.42% sequentially from $13616.0 in Q3 2024.
Mangoceuticals (MGRX) Inventory Average (2023 - 2024) Analysis & Trends
Mangoceuticals (MGRX) has 2 years of Inventory Average data on file, last reported at -$2644.0 in Q4 2024.
- For the quarter ending Q4 2024, Inventory Average fell 113.19% year-over-year to -$2644.0; the trailing twelve-month figure through Dec 2024 stood at -$2644.0 (down 113.19% YoY), and the FY2024 full-year result was $0.0, changed N/A from the prior year.
- Inventory Average slipped to -$2644.0 in Q4 2024, from $13616.0 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $22537.5 in Q3 2023 to a low of -$2644.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn | 687.67 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn | 14.90 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn | 54.91 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn | 374.50 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn | - |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn | - |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - | - |
| 10 | Mangoceuticals | 9.39 Mn | 9.20 Mn | 29,001.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2,644.00 |
| Sep 30, 2024 | 13,616.00 |
| Jun 30, 2024 | 14,235.50 |
| Mar 31, 2024 | 16,476.50 |
| Dec 31, 2023 | 20,041.00 |
| Sep 30, 2023 | 22,537.50 |